Regardless of your preference, the market is clearly loving any sort of positive vaccine data. After months of yearning for signs of an accelerated economic recovery and overall return to normalcy, investors are finally getting something to cheer about — and they've reacted by smashing the buy button.
Alex Umansky's Baron Global Advantage Fund has been at the top of its class for years and brought more than 60% to investors in 2020. Kiplinger rates his fund as the best global stock fund of the last year, the last three years, and the last five years for periods ending September 30.
William Danoff, the portfolio manager of Fidelity's Contrafund (FCNTX), was initially rejected by Fidelity before coming aboard as an analyst in 1986. At the helm of Fidelity's Contrafund, Danoff has handily beaten the S&P 500 by over 300 basis points on average over a 30-year stretch, according to Barron's.
Danoff is a growth investor through and through, and that's coerced his portfolio's tilt into technology names. he shares 10 rules for investing that have ensured his success along the way.
"Many of the stocks trading with the lowest valuations today are those with business models most directly harmed by the pandemic and its impact on economic activity. The vaccine announcement by [Pfizer] provided evidence that a path to normalization exists, which should serve as a catalyst for Value stock outperformance."
-- David Kostin, chief US equity strategist at Goldman Sachs